Table 1.
differences between patients admitted to the hospital and those managed as outpatients.
| Hospital admission (N = 69) | Outpatients (N =88) | Difference (95% CI) | |
|---|---|---|---|
| Age, years, mean (SD) | 74.4 (10.6) | 66.9 (12.6) | 7.5 (3.7 – 11.2) |
| Male sex, n (%) | 36 (52.1%) | 35 (39.7%) | 12.4% (-3.2 – 27.2) |
| DM, n° (%) | 31 (44.9%) | 22 (25%) | 19.9% (4.9 – 34.0) |
| DLP, n° (%) | 42 (60.8%) | 39 (44.3%) | 16.5% (0.8 – 31.1) |
| ACEI, n° (%) | 12 (17.3%) | 20 (22.7%) | -5.3% (-17.4 – 7.6) |
| ARB, n° (%) | 36 (52.1%) | 53 (60.2%) | -8.0% (-23.0 – 7.3) |
| CCB, n° (%) | 23 (33.3%) | 21 (23.8%) | 9.4% (-4.5 – 23.5) |
| Diuretics, n° (%) | 30 (43.4%) | 36 (40.9%) | 2.5% (-12.6 – 17.7) |
| BB, n° (%) | 23 (33.3%) | 24 (27.2%) | 6.0% (-8.1 – 20.3) |
| Number of antihypertensive drugs | |||
| 0, n° (%) | 2 (2.9%) | 3 (3.4%) | -0.5% (-7.0 – 6.9) |
| 1, n° (%) | 28 (40.5%) | 34 (38.6%) | 1.9% (-13.0 – 17.0) |
| 2, n° (%) | 22 (31.8%) | 34 (38.6%) | -6.7% (-21.0 – 8.3) |
| 3, n° (%) | 15 (21.7%) | 15 (17.0%) | -4.6% (-7.5 – 17.5) |
| 4, n° (%) | 2 (2.9%) | 2 (2.2%) | 0.6% (-5.3 – 7.8) |
| CVD, n° (%) | 23 (33.3%) | 13 (14.7%) | 18.5% (5.2 – 31.7) |
| CHF, n° (%) | 1 (1.4%) | 2 (2.2%) | -0.8% (-6.5 – 5.7) |
| CD, n° (%) | 10 (14.4%) | 8 (9.0%) | 5.4% (-4.7 – 16.4) |
| VHD, n° (%) | 2 (2.9%) | 3 (3.4%) | -0.5% (-7.0 – 6.9) |
| AF, n° (%) | 8 (11.5%) | 7 (7.9%) | 3.6% (-5.7 – 14.1) |
| HM, n° (%) | 7 (10.1%) | 1 (1.1%) | 9.0% (1.8 – 18.4) |
CI: confidence interval; DM: diabetes mellitus; DLP: dyslipidemia; ACEI: ACEI: angiotensin converting enzyme inhibitors; ARB: angiotensin-II receptor blockers; CCB: calcium channel blockers; BB: beta-blockers; CVD: cardiovascular disease (any); CHF: chronic heart failure; CD: coronary disease; VHD: valvular heart disease; AF: atrial fibrillation; HM: hypertensive myocadiopathy. Some patients were diagnosed with more than one CVD.